County

Riverside County Emergency Medical Services Agency (REMSA)

Current149 dose entries29 drugs2 documentsCAeffective 2025-07-0196% machine-parsed of 149

Riverside County Emergency Medical Services Agency (REMSA) (CA) carries 29 drugs across 149 dose entries in its current published protocol, effective 2025-07-01.

Drugs and doses29

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	1 g	IV	not captured	standing	page 186
Fever	peds	15 mg/kg	IV	not captured	standing	page 186
Mild to moderate pain	adult	1 g	IV	not captured	standing	page 186
Mild to moderate pain	peds	15 mg/kg	IV	not captured	standing	page 186

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	12 mg	IV	not captured	standing	page 187
SVT	peds	0.2 mg/kg	IV	not captured	standing	page 187

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	page 189
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	page 189
Hyperkalemia	adult	2.5 mg	NEB	not captured	standing	page 189
Hyperkalemia	peds	2.5 mg	NEB	not captured	standing	page 189
Other	adult	5 mg	NEB	not captured	standing	page 189

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	300 mg	IV	not captured	standing	page 190
Cardiac arrest	peds	5 mg/kg	IV	not captured	standing	page 190
Narrow-complex tachycardia	adult	150 mg	IV	not captured	standing	page 190
Narrow-complex tachycardia	peds	5 mg/kg	IV	not captured	standing	page 190

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	page 191

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV	not captured	standing	page 192
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	page 192
Cardiac arrest	adult	1 mg	IV	not captured	standing	page 192
Nerve agent exposure	adult	1 mg	IV	not captured	standing	page 192
Nerve agent exposure	adult	2 mg	IM	not captured	standing	page 192
Nerve agent exposure	peds	0.02 mg/kg	IV	not captured	standing	page 192
Nerve agent exposure	peds	0.05 mg/kg	IM	not captured	standing	page 192

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 g	IV	not captured	standing	page 193
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV	not captured	standing	page 193
Cardiac arrest	adult	1 g	IV	not captured	standing	page 193
Cardiac arrest	peds	20 mg/kg	IV	not captured	standing	page 193
Hyperkalemia	adult	1 g	IV	not captured	standing	page 193
Hyperkalemia	adult	1 g	IV	not captured	standing	page 193
Hyperkalemia	adult	1 g	IV	not captured	standing	page 193
Hyperkalemia	peds	20 mg/kg	IV	not captured	standing	page 193
Hyperkalemia	peds	20 mg/kg	IV	not captured	standing	page 193
Hyperkalemia	peds	20 mg/kg	IV	not captured	standing	page 193
Other	adult	1 g	IV	not captured	standing	page 193
Other	adult	1 g	IV	not captured	standing	page 193
Other	peds	20 mg/kg	IV	not captured	standing	page 193

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	25 g	IV/IO	not captured	standing	page 195
Hypoglycemia	peds	5 mL/kg	IV/IO	not captured	standing	page 195
Neonatal resuscitation	peds	5 mL/kg	IV/IO	not captured	standing	page 195

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	10 mg	IM	not captured	standing	page 156
Nerve agent exposure	adult	2.5 mg	IV	not captured	standing	page 156
Nerve agent exposure	peds	0.1 mg/kg	IM	not captured	standing	page 156

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	50 mg	IV/IM	not captured	standing	page 196
Anaphylaxis	peds	1 mg/kg	IV/IM	not captured	standing	page 196
Dystonic reaction	adult	50 mg	IV/IM	not captured	standing	page 196
Dystonic reaction	peds	1 mg/kg	IV/IM	not captured	standing	page 196
Nausea / vomiting	adult	25–50 mg	IV/IM	not captured	standing	page 196
Nausea / vomiting	peds	1 mg/kg	IV/IM	not captured	standing	page 196

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	page 198
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	page 198
Cardiac arrest	adult	1 mg	IV	not captured	standing	page 197
Cardiac arrest	peds	0.01 mg/kg	IV	not captured	standing	page 197
Croup	peds	0.5 mg/kg	NEB	not captured	standing	page 197
Hypotension / shock	adult	0.01 mg	IV	not captured	standing	page 197
Respiratory distress	adult	0.3 mg	IM	not captured	standing	page 198
Respiratory distress	peds	0.01 mg/kg	IM	not captured	standing	page 198

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	50 mcg	IV/IM/IN	not captured	standing	page 200
Mild to moderate pain	peds	1 mcg/kg	IV/IM/IN	not captured	standing	page 200
Post-ROSC care	adult	Dosing dependent on pain	IV/IM/IN	not captured	standing	page 200
Procedural sedation	adult	50 mcg	IV/IM/IN	not captured	standing	page 200
Procedural sedation	peds	1 mcg/kg	IV/IM/IN	not captured	standing	page 200

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV/IM	not captured	standing	page 202
Beta-blocker / calcium-channel-blocker overdose	peds	50 mcg/kg	IV/IM	not captured	standing	page 202
Hypoglycemia	adult	1 mg	IM	not captured	standing	page 202
Hypoglycemia	peds	0.5 mg	IM	not captured	standing	page 202
Neonatal resuscitation	peds	0.5 mg	IM	not captured	standing	page 202
Other	adult	1 mg	IV/IM	not captured	standing	page 202
Other	peds	0.5 mg	IV/IM	not captured	standing	page 202

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	page 205
Asthma / bronchospasm	peds	0.5 mg	NEB	not captured	standing	page 205

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	0.3 mg/kg	IV	not captured	standing	page 157
Mild to moderate pain	adult	0.5 mg/kg	IN	not captured	standing	page 157
Procedural sedation	adult	0.5 mg/kg	IN	not captured	standing	page 157

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV	not captured	standing	page 167
Mild to moderate pain	adult	15 mg	IV	not captured	standing	page 167
Mild to moderate pain	adult	30 mg	IM	not captured	standing	page 167
Mild to moderate pain	adult	30 mg	IM	not captured	standing	page 167
Mild to moderate pain	peds	0.5 mg/kg	IV	not captured	standing	page 167
Mild to moderate pain	peds	0.5 mg/kg	IM	not captured	standing	page 167
Mild to moderate pain	peds	0.5 mg/kg	IV	not captured	standing	page 167
Mild to moderate pain	peds	0.5 mg/kg	IM	not captured	standing	page 167
Severe pain	adult	15 mg	IV	not captured	standing	page 167
Severe pain	adult	30 mg	IM	not captured	standing	page 167
Severe pain	peds	0.5 mg/kg	IV	not captured	standing	page 167
Severe pain	peds	0.5 mg/kg	IM	not captured	standing	page 167

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	50 mg	not captured	not captured	standing	page 166
Mild to moderate pain	peds	0.5 mg/kg	not captured	not captured	standing	page 166
Narrow-complex tachycardia	adult	1 mg/kg	IV	not captured	standing	page 208
Narrow-complex tachycardia	peds	1 mg/kg	IV	not captured	standing	page 208
VF / pulseless VT	adult	1 mg/kg	IV	not captured	standing	page 208
VF / pulseless VT	peds	1 mg/kg	IV	not captured	standing	page 208

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2.6 mg	IV/IN	not captured	standing	page 158
Agitation	peds	0.1 mg/kg	IM	not captured	standing	page 158
Mild to moderate pain	adult	1.2 mg	IV/IO	not captured	standing	page 157
Mild to moderate pain	adult	1.2 mg	IM/IN	not captured	standing	page 157

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV	not captured	standing	page 209
Asthma / bronchospasm	peds	50 mg/kg	IV	not captured	standing	page 209
Eclampsia / pre-eclampsia	adult	5 g	IV/IM	not captured	standing	page 209
Other	adult	2 g	IV	not captured	standing	page 209
Other	peds	50 mg/kg	IV	not captured	standing	page 209
VF / pulseless VT	adult	2 g	IV	not captured	standing	page 209
VF / pulseless VT	peds	50 mg/kg	IV	not captured	standing	page 209

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Head injury / TBI	adult	2.5 mg	IV	not captured	standing	page 212
Head injury / TBI	adult	5 mg	IM/IN	not captured	standing	page 212
Head injury / TBI	peds	0.1 mg/kg	IV	not captured	standing	page 212
Head injury / TBI	peds	0.2 mg/kg	IM/IN	not captured	standing	page 212
Other	adult	1 mg	IV/IM/IN	not captured	standing	page 210
Post-ROSC care	adult	1 mg	IV/IM/IN	not captured	standing	page 210
Seizure	adult	2.5 mg	IV	not captured	standing	page 211
Seizure	adult	5 mg	IM/IN	not captured	standing	page 211
Seizure	peds	0.1 mg/kg	IV	not captured	standing	page 211
Seizure	peds	0.2 mg/kg	IM/IN	not captured	standing	page 211

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	5 mg	IV/IM	not captured	standing	page 158
Mild to moderate pain	adult	5 mg	IV	not captured	standing	page 159
Mild to moderate pain	peds	0.1 mg/kg	IV/IM	not captured	standing	page 158
Mild to moderate pain	peds	0.1 mg/kg	IV	not captured	standing	page 159

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Neonatal resuscitation	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	page 213
Opioid overdose	adult	1 mg	IN	not captured	standing	page 213
Opioid overdose	adult	1 mg	IV	not captured	standing	page 213
Opioid overdose	adult	1 mg	IM	not captured	standing	page 213
Opioid overdose	peds	0.1 mg/kg	IN	not captured	standing	page 213
Opioid overdose	peds	0.1 mg/kg	IV	not captured	standing	page 213
Opioid overdose	peds	0.1 mg/kg	IM	not captured	standing	page 213

Nerve Agent Antidote Kit

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	1 injection (both syringes)	IM	not captured	standing	page 156
Nerve agent exposure	adult	1 injection (both syringes)	IM	not captured	standing	page 156

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	page 214
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 214

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	PO	not captured	standing	page 217
Nausea / vomiting	adult	4 mg	IV	not captured	standing	page 217
Nausea / vomiting	adult	4 mg	IM	not captured	standing	page 217
Nausea / vomiting	peds	0.1 mg/kg	IV	not captured	standing	page 217
Nausea / vomiting	peds	0.1 mg/kg	IM	not captured	standing	page 217
Nausea / vomiting	peds	4 mg	PO	not captured	standing	page 217

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15 g	PO	not captured	standing	page 204
Hypoglycemia	peds	As tolerated	PO	not captured	standing	page 204

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	600 mg	IM	not captured	standing	page 157
Nerve agent exposure	adult	600 mg	IV	not captured	standing	page 157
Nerve agent exposure	peds	20 mg/kg	IM	not captured	standing	page 157
Nerve agent exposure	peds	20 mg/kg	IV	not captured	standing	page 157

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	50 mEq	IV	not captured	standing	page 218
Cardiac arrest	peds	1 mEq/kg	IV	not captured	standing	page 218
Hyperkalemia	adult	50 mEq	IV	not captured	standing	page 218
Hyperkalemia	peds	1 mEq/kg	IV	not captured	standing	page 218
Neonatal resuscitation	peds	1 mEq/kg	IV	not captured	standing	page 218
Other	adult	50 mEq	IV	not captured	standing	page 218
Other	adult	50 mEq	IV	not captured	standing	page 218
Other	peds	1 mEq/kg	IV	not captured	standing	page 218

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Obstetric hemorrhage	adult	1 g	IV/IO	not captured	standing	page 219
Trauma / hemorrhage	adult	1 g	IV/IO	not captured	standing	page 219

Cite this

Riverside County Emergency Medical Services Agency (REMSA), United States EMS Protocol Census. 149 dose entries, effective 2025-07-01.

https://protoquiz.com/census/agencies/riverside-county-emergency-medical-services-agency-remsa/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.